Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 31
Titolo Data di pubblicazione Autori File
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 1-gen-2003 RIMONDI, ErikaCELEGHINI, CLAUDIO +
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points:induction of apoptosis and PGE2 release. 1-gen-2003 RIMONDI, ErikaNICOLIN, VANESSAGRILL, VITTORIO +
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. 1-gen-2004 RIMONDI, ErikaCORALLINI, FEDERICAGRILL, VITTORIO +
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 1-gen-2004 RIMONDI, ErikaNICOLIN, VANESSACELEGHINI, CLAUDIO +
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors. 1-gen-2007 RIMONDI, ErikaCORALLINI, FEDERICA +
MDM2 antagonist nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts via a p53-dependent pathway. 1-gen-2007 RIMONDI, ErikaCORALLINI, FEDERICA +
Receptor activator of nuclear factor kappa B ligand(RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts. 1-gen-2007 RIMONDI, ErikaZWEYER, MARINA +
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 1-gen-2008 RIMONDI, ErikaGRILL, VITTORIOCELEGHINI, CLAUDIO +
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 1-gen-2008 RIMONDI, ErikaRUSTIGHI, ALESSANDRADEL SAL, GIANNINO +
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 1-gen-2009 RIMONDI, ErikaGRILL, VITTORIOCELEGHINI, CLAUDIO +
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 1-gen-2009 RIMONDI, ErikaGRILL, VITTORIO +
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 1-gen-2010 RIMONDI, ErikaCELEGHINI, CLAUDIO +
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 1-gen-2011 CELEGHINI, CLAUDIORIMONDI, Erika +
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 1-gen-2011 CELEGHINI, CLAUDIORIMONDI, Erika +
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 1-gen-2011 CELEGHINI, CLAUDIORIMONDI, Erika +
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 1-gen-2012 RIMONDI, ErikaCELEGHINI, CLAUDIO +
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1. 1-gen-2012 RIMONDI, ErikaGRILL, VITTORIO +
Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells. 1-gen-2013 RIMONDI, Erika +
C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway. 1-gen-2013 RIMONDI, Erika +
Levels of TNF-related apoptosis-inducing ligand (TRAIL) show a long-term stability in the breast milk of mothers of preterm infants. 1-gen-2013 RIMONDI, Erika +
Mostrati risultati da 1 a 20 di 31
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile